Johnson & Johnson to begin human trials of COVID-19 vaccine in July
Johnson & Johnson said it would start human trials of its potential COVID-19 vaccine in July. As many as 1,045 healthy people aged 18-55, as well as those 65 and older will participate in the
Johnson & Johnson said it would start human trials of its potential COVID-19 vaccine in July. As many as 1,045 healthy people aged 18-55, as well as those 65 and older will participate in the trial. J&J has already signed a deal with the US government to create enough manufacturing capacity to make over 1 billion doses of its vaccine.
